Factors associated with anticholinergic burden among older patients in long-term care hospitals in Korea
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Drugs with anticholinergic properties (DAPs) are associated with adverse health outcomes in older patients. The objective of this study was to evaluate the factors that determine the prescribing of more DAPs in long-term care hospitals (LTCHs) in Korea. In addition, the current patterns of DAP prescription were explored using a novel platform, which can collect data from LTCHs. Methods: This was a Health-RESPECT (integrated caRE Systems for elderly PatiEnts using iCT) sub-study, which is a pragmatic, cluster-randomized, controlled trial. The Health-RESPECT platform was used to collect prescribed medication data of 466 patients (aged ≥ 65 years) from seven LTCHs. DAPs were identified using the Korean Anticholinergic Burden Scale (KABS). Physical frailty, cognitive function, functional status, and quality of life were evaluated. Results: Among 466 LTCH patients, 88.8% (n = 414) were prescribed DAPs, and the prevalence of high KABS (≥ 3) was 70.4% (n = 328). The drugs that contributed most to the total KABS were quetiapine (20.7%), chlorpheniramine (19.5%), tramadol (9.8%), cimetidine (5.8%), and furosemide (3.6%). Polypharmacy, higher body mass index, less dependence, better communication and cognitive functions, and poorer quality of life were associated with high KABS. Conclusions: Although the patients with a high burden of DAPs were less dependent and had better cognitive and communication functions, they had poorer quality of life. DAP use in LTCH patients should be monitored carefully, and the risk/ benefit relationship for their use should be considered.
Abstract
Background/Aims: Drugs with anticholinergic properties (DAPs) are associated with adverse health outcomes in older patients. The objective of this study was to evaluate the factors that determine the prescribing of more DAPs in long-term care hospitals (LTCHs) in Korea. In addition, the current patterns of DAP prescription were explored using a novel platform, which can collect data from LTCHs. Methods: This was a Health-RESPECT (integrated caRE Systems for elderly PatiEnts using iCT) sub-study, which is a pragmatic, cluster-randomized, controlled trial. The Health-RESPECT platform was used to collect prescribed medication data of 466 patients (aged ≥ 65 years) from seven LTCHs. DAPs were identified using the Korean Anticholinergic Burden Scale (KABS). Physical frailty, cognitive function, functional status, and quality of life were evaluated. Results: Among 466 LTCH patients, 88.8% (n = 414) were prescribed DAPs, and the prevalence of high KABS (≥ 3) was 70.4% (n = 328). The drugs that contributed most to the total KABS were quetiapine (20.7%), chlorpheniramine (19.5%), tramadol (9.8%), cimetidine (5.8%), and furosemide (3.6%). Polypharmacy, higher body mass index, less dependence, better communication and cognitive functions, and poorer quality of life were associated with high KABS. Conclusions: Although the patients with a high burden of DAPs were less dependent and had better cognitive and communication functions, they had poorer quality of life. DAP use in LTCH patients should be monitored carefully, and the risk/ benefit relationship for their use should be considered.
참고문헌 (37)
- "Statistics on the aged 2019" (2019)[URL]
- Ga H, "Perspective on long term care hospitals in Korea", J Am Med Dir Assoc, 14, pp.770~772 (2013)
- Hyuk Ga, "Long-Term Care System in Korea", Annals of geriatric medicine and research, 24(3), pp.181~186 (2020), 대한노인병학회[DOI]
- Kim H, "A decade of public long-term care insurance in South Korea : policy lessons for aging countries", Health Policy, 125, pp.22~26 (2021)
- Maher RL, "Clinical consequences of polypharmacy in elderly", Expert Opin Drug Saf, 13, pp.57~65 (2014)
- By the 2019 American Geriatrics Society Beers Criteria®Update Expert Panel, "American Geriatrics Society 2019Updated AGS Beers Criteria® for potentially inappropriate medication use in older adults", J Am Geriatr Soc, 67, pp.674~694 (2019)
- Rudolph JL, "The anticholinergic risk scale and anticholinergic adverse effects in older persons", Arch Intern Med, 168, pp.508~513 (2008)
- Tune LE, "Anticholinergic effects of medication in elderly patients", J Clin Psychiatry, 62(Suppl 21), pp.11~14 (2001)
- Onder G, "Polypharmacy in nursing home in Europe : results from the SHELTER study", J Gerontol A Biol Sci Med Sci, 67, pp.698~704 (2012)
- Cullinan S, "Use of a frailty index to identify potentially inappropriate prescribing and adverse drug reaction risks in older patients", Age Ageing, 45, pp.115~120 (2016)
- Calderon-Larranaga A, "Multimorbidity, polypharmacy, referrals, and adverse drug events : are we doing things well", Br J Gen Pract, 62, pp.e821~e826 (2012)
- Rochon PA, "The prescribing cascade revisited", Lancet, 389, pp.1778~1780 (2017)
- Salahudeen MS, "Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people : a systematic review", BMC Geriatr, 15, pp.31~ (2015)
- Jun K, "Development of an Anticholinergic Burden Scale specific for Korean older adults", Geriatr Gerontol Int, 19, pp.628~634 (2019)
- Suh Y, "Dose response relationship of cumulative anticholinergic exposure with incident dementia : validation study of Korean anticholinergic burden scale", BMC Geriatr, 20, pp.265~ (2020)
- Jung-Yeon Choi, "Development of Health-RESPECT: An Integrated Service Model for Older Long-Term Care Hospital", Nursing Home Patients Using Information and Communication Technology, 2020, pp.24(1), 27~34[DOI]
- Choi JY, "Validation of an integrated service model, Health-RESPECT, for older patients in longterm care institution using information and communication technologies : protocol of a cluster randomised controlled trial", BMJ Open, 10, pp.e038598~ (2020)
- 이민호, "Developing a Common Health Information Exchange Platform to Implement a Nationwide Health Information Network in South Korea", Healthcare Informatics Research, 21(1), pp.21~29 (2015), 대한의료정보학회[DOI]
- 정희원, "The Korean version of the FRAIL scale: clinical feasibility and validity of assessing the frailty status of Korean elderly", The Korean Journal of Internal Medicine, 31(3), pp.594~600 (2016), 대한내과학회
- Frijters DH, "The calculation of quality indicators for long term care facilities in 8 countries(SHELTER project)", BMC Health Serv Res, 13, pp.138~ (2013)
- Kim H, "Reliability of the interRAI Long Term Care Facilities(LTCF)and interRAI Home Care(HC)", Geriatr Gerontol Int, 15, pp.220~228 (2015)
- Morris JN, "Scaling ADLs within the MDS", J Gerontol A Biol Sci Med Sci, 54, pp.M546~M553 (1999)
- Burrows AB, "Development of a minimum data set-based depression rating scale for use in nursing homes", Age Ageing, 29, pp.165~172 (2000)
- Frederiksen K, "Minimum Data Set Plus(MDS+)scores compared with scores from five rating scales", J Am Geriatr Soc, 44, pp.305~309 (1996)
- Fries BE, "Pain in U. S. nursing homes : validating a pain scale for the minimum data set", Gerontologist, 41, pp.173~179 (2001)
- Kim SH, "The EQ-5D-5L valuation study in Korea", Qual Life Res, 25, pp.1845~1852 (2016)
- Mehrholz J, "Predictive validity and responsiveness of the functional ambulation category in hemiparetic patients after stroke", Arch Phys Med Rehabil, 88, pp.1314~1319 (2007)
- Masnoon N, "What is polypharmacy? : a systematic review of definitions", BMC Geriatr, 17, pp.230~ (2017)
- 백안나, "개정된 원내 노인부적절약물 목록을 활용한 외래환자의 약물사용평가 및 약제비 절감효과 분석", 병원약사회지, 31(3), pp.785~794 (2014), 한국병원약사회[DOI]
- Aalto UL, "Use of anticholinergic drugs and its relationship with psychological well-being and mortality in long-term care facilities in Helsinki", J Am Med Dir Assoc, 19, pp.511~515 (2018)
- Haasum Y, "Institutionalization as a risk factor for inappropriate drug use in the elderly : a Swedish nationwide register-based study", Ann Pharmacother, 46, pp.339~346 (2012)
- Palmer JB, "Use of drugs with anticholinergic properties among nursing home residents with dementia : a national analysis of medicare beneficiaries from 2007 to 2008", Drugs Aging, 32, pp.79~86 (2015)
- Kumpula EK, "Anticholinergic drug use and mortality among residents of long-term care facilities : a prospective cohort study", J Clin Pharmacol, 51, pp.256~263 (2011)
- Bottiggi KA, "Long-term cognitive impact of anticholinergic medications in older adults", Am J Geriatr Psychiatry, 14, pp.980~984 (2006)
- Egberts A, "Anticholinergic drug burden and delirium : a systematic review", J Am Med Dir Assoc, 22, pp.65~73 (2021)
- Pfistermeister B, "Anticholinergic burden and cognitive function in a large German cohort of hospitalized geriatric patients", PLoS One, 12, pp.e0171353~ (2017)
- Nishtala PS, "Anticholinergics : theoretical and clinical overview", Expert Opin Drug Saf, 15, pp.753~768 (2016)